Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation

IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation

US Patent 11292788 · Granted Apr 5, 2022

Estimated economic value: $5,806,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of multiple sclerosis comprising DHODH inhibitors2025
Treatment of multiple sclerosis comprising DHODH inhibitors2025
Dosage regimen2025
Vidofludimus for use in the treatment or prevention of viral diseases2024
Vidofludimus for use in the treatment or prevention of viral diseases2024
Vidofludimus for use in the treatment or prevention of viral diseases2024
Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-prolifer2024
Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-prolifer2024
Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-prolifer2024
Treatment of multiple sclerosis comprising DHODH inhibitors2024
Treatment of multiple sclerosis comprising DHODH inhibitors2024
Compounds and dosage regimen for use in the prevention or treatment of chronic i2024